Targeted pill trial offers hope for tough cancers with genetic flaw
NCT ID NCT06385483
Summary
This study is testing whether a pill called afatinib can help control advanced cancers that have a specific genetic change (EGFR mutation) and have stopped responding to standard treatments. It is for adults with various solid tumors or lymphomas (but not lung cancer or certain brain tumors). The goal is to see if blocking the faulty genetic signal can slow or shrink the cancer.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED LYMPHOMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
ECOG-ACRIN Cancer Research Group
Philadelphia, Pennsylvania, 19103, United States
Conditions
Explore the condition pages connected to this study.